Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study) by Bjune T, Bøe TB, Kjellevold SA, Heldal K, Abedini S

Subjects: “…chronic kidney disease – hyperkalemia – potassium-binder – raasi…”
Get full text

Sodium zirconium cyclosilicate hydrate reduces medical expenses compared with hemodialysis in patients with acute hyperkalemia by Hayato Fujioka, Teruhiko Imamura, Tsutomu Koike, Shingo Yokoyama, Kota Kakeshita, Hidenori Yamazaki, Koichiro Kinugawa

Subjects: Get full text

Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden by Kun Kim, Josefine Fagerström, Gengshi Chen, Zoya Lagunova, Hans Furuland, Phil McEwan

Subjects: Get full text

A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database by Sharma A, Alvarez PJ, Woods SD, Dai D

Subjects: Get full text

The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure by Daniel Murphy, Irina Chis Ster, Juan-Carlos Kaski, Lisa Anderson, Debasish Banerjee

Subjects: Get full text

The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study by Hajime Nagasu, Atsuyuki Tokuyama, Eiichiro Kanda, Seiji Itano, Seiji Kishi, Tamaki Sasaki, Naoki Kashihara

Subjects: Get full text

Hyperkalemia: Prevalence, Predictors and Emerging Treatments by Natasha L. Larivée, Jacob B. Michaud, Keigan M. More, Jo-Anne Wilson, Karthik K. Tennankore

Subjects: Get full text

Hyperkalemia in CKD: an overview of available therapeutic strategies by Davide Costa, Gemma Patella, Michele Provenzano, Nicola Ielapi, Teresa Faga, Mariateresa Zicarelli, Franco Arturi, Giuseppe Coppolino, Davide Bolignano, Giovambattista De Sarro, Umberto Marcello Bracale, Luca De Nicola, Paolo Chiodini, Raffaele Serra, Michele Andreucci

Subjects: Get full text

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia by Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, Eva Lesén, Abiy Agiro, Matthew Arnold, Gengshi Chen, Toshitaka Yajima, Krister Järbrink, Charles V. Pollack

Subjects: Get full text

Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study by Agiro A, Dwyer JP, Oluwatosin Y, Desai P

Subjects: Get full text

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life by Alberto Esteban‐Fernández, Carolina Ortiz Cortés, Silvia López‐Fernández, Alejandro Recio Mayoral, Francisco Javier Camacho Jurado, Inés Gómez Otero, María Molina, Luis Almenar Bonet, Raquel López‐Vilella

Subjects: Get full text

Ci Sono Novità in Tema di Controllo Del Potassio? by Andrea Cavalli, Maria Carmen Luise, Giuseppe Pontoriero

Subjects: Get full text

Management of hyperkalemia: Expert consensus from Kuwait – a Modified Delphi Approach by AlSahow A, Bulbanat B, Alhelal B, Alhumoud K, Alkharaza A, Alotaibi T, Alrajab H, Alyousef A, Hadi F

Subjects: Get full text

Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study by Eiichiro Kanda, Naru Morita, Toshitaka Yajima

Subjects: Get full text

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options by Enrique Morales, Enrique Morales, Enrique Morales, Paolo Cravedi, Joaquin Manrique, Joaquin Manrique

Subjects: Get full text

Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K) by Haijiao Jin, Renhua Lu, Lihong Zhang, Li Yao, Guojian Shao, Li Zuo, Shuguang Qin, Xinzhou Zhang, Qinghong Zhang, Weimin Yu, Qun Luo, Yuqing Ren, Hui Peng, Jie Xiao, Qiongqiong Yang, Qinkai Chen, Yifan Shi, Zhaohui Ni

Subjects: Get full text

The efficacy and safety of new potassium binders on renin–angiotensin–aldosterone system inhibitor optimization in heart failure patients: a systematic review and meta‐analysis... by Mohamed Abuelazm, Amr Badr, Mustafa Turkmani, Mostafa Atef Amin, Ahmed Mazen Amin, Aya Aboutaleb, Ibrahim Gowaily, Youssef Soliman, Basel Abdelazeem

Subjects: “…New potassium binders…”
Get full text

Patiromer and medication optimisation in heart failure with reduced ejection fraction: a Swiss perspective by Philippe Meyer, Henri Lu, Roger Hullin

Subjects: Get full text